ATH 25.0% 0.3¢ alterity therapeutics limited

LMTM Trial results, page-6

  1. 1,847 Posts.
    lightbulb Created with Sketch. 1
    ALZ-801 targets amyloid. Point is they have returned after a "failure."
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.